id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1995-S-0036-0109,FDA,FDA-1995-S-0036,"Report 38 - Baylor College of Medicine Public Disclosure on IND 100,681",Other,RPT-Report,2009-12-31T05:00:00Z,2009,12,2009-12-31T05:00:00Z,,2013-07-27T23:02:32Z,,0,0,0900006480a6b5ec
FDA-1995-S-0036-0108,FDA,FDA-1995-S-0036,Report 37 - Laerdal Medical Public Disclosure on IDE No. G020121,Other,RPT-Report,2009-09-02T04:00:00Z,2009,9,2009-09-02T04:00:00Z,,2013-07-27T22:52:13Z,,0,0,0900006480a0c79e
FDA-1995-S-0036-0107,FDA,FDA-1995-S-0036,Report 36 - Georgetown University Medical Center (IDE # GO50077-MR & Recanalization of Stroke Clots Using Embolectiomy (MR RESCUE),Other,RPT-Report (outside of agency unless indicated),2009-08-13T04:00:00Z,2009,8,2009-08-13T04:00:00Z,,2013-07-27T22:50:15Z,,0,0,09000064809fb0d8
FDA-1995-S-0036-0106,FDA,FDA-1995-S-0036,"University of Washington School of Medicine re Normal Saline Infusin at 4 Degree Celsius,  Public Disclosure Material Progress Report for IND 69,382 Report 35",Other,Report,2009-08-03T04:00:00Z,2009,8,2009-08-03T04:00:00Z,,2014-11-28T20:02:14Z,,0,0,09000064809f46dd
FDA-1995-S-0036-0104,FDA,FDA-1995-S-0036,"Report 17 - Northfield Laboratories, Inc. - Public Disclosure Information",Other,RPT-Report (outside of agency unless indicated),2009-06-11T04:00:00Z,2009,6,2009-06-11T04:00:00Z,,2021-02-05T19:06:41Z,,0,0,090000648055b0b9
FDA-1995-S-0036-0105,FDA,FDA-1995-S-0036,"Report 17 - ""Lehigh Valley Hospital"" - [Northfield Laboratories, Inc. - Public Disclosure Information]",Supporting & Related Material,RPT-Report (Supporting and Related Material),2009-06-11T04:00:00Z,2009,6,,,2021-02-05T19:06:41Z,,0,0,090000648055b0bc
FDA-1995-S-0036-0103,FDA,FDA-1995-S-0036,"Supplement Public Disclosure Material from Advanced Circulatory Systems, Inc., re IDE #G050062",Other,SUP-Supplement,2009-06-10T04:00:00Z,2009,6,2009-06-10T04:00:00Z,,2014-11-28T19:56:26Z,,0,0,09000064809c4c90
FDA-1995-S-0036-0102,FDA,FDA-1995-S-0036,"Resuscitation Outcomes Consortium (ROC), INDs 12505 & 12506 Public Disclosure Material Report 34 - Report",Other,Report,2009-02-10T05:00:00Z,2009,2,2009-02-10T05:00:00Z,,2021-02-05T19:05:15Z,,0,0,0900006480847da9
FDA-1995-S-0036-0029,FDA,FDA-1995-S-0036,Baxter INDA#6859 - Supplement 7,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:29Z,,0,0,090000648055afe6
FDA-1995-S-0036-0038,FDA,FDA-1995-S-0036,Baxter INDA#6859,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:35Z,,0,0,090000648055afff
FDA-1995-S-0036-0042,FDA,FDA-1995-S-0036,Icos Corporation BB IND-7371,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:40Z,,0,0,090000648055b025
FDA-1995-S-0036-0099,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:14Z,,0,0,090000648055b0da
FDA-1995-S-0036-0070,FDA,FDA-1995-S-0036,"Northfield Laboratories Inc, BB IND 10719, Poly-SFH-P Injection",Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:52Z,,0,0,090000648055b200
FDA-1995-S-0036-0079,FDA,FDA-1995-S-0036,Report 19 - William Beaumont Hospital - Public Disclosure Information,Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:05:00Z,,0,0,090000648055b2f2
FDA-1995-S-0036-0030,FDA,FDA-1995-S-0036,"Cardiologic Systems, Inc IDE G960214/S5 - SUP11",Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:29Z,,0,0,090000648055afeb
FDA-1995-S-0036-0032,FDA,FDA-1995-S-0036,"Cardiologic Systems, Inc IDE G960214/9",Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:31Z,,0,0,090000648055aff0
FDA-1995-S-0036-0035,FDA,FDA-1995-S-0036,"Cardiologic Systems, Inc IDE G960214",Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:33Z,,0,0,090000648055aff5
FDA-1995-S-0036-0037,FDA,FDA-1995-S-0036,Baxter INDA#6859,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:34Z,,0,0,090000648055affd
FDA-1995-S-0036-0084,FDA,FDA-1995-S-0036,Memphis Paper - [Report 3 - ICOS Corp. (BB IND-7371) - Public Disclosure Information],Supporting & Related Material,RPT-Report (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:04Z,,0,0,090000648055b00f
FDA-1995-S-0036-0048,FDA,FDA-1995-S-0036,Report 11 - Public Access Defibrillation (PAD) Trial - [IDE #G980067] - Public Disclosure Information,Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:37Z,,0,0,090000648055b084
FDA-1995-S-0036-0085,FDA,FDA-1995-S-0036,"Listing 1 - Memphis Survey Results, October 9, 2003 - [Report 12 - Northfield Laboratories, Inc. - Public Disclosure Information] Part 2 of 3",Supporting & Related Material,RPT-Report (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:05Z,,0,0,090000648055b087
FDA-1995-S-0036-0053,FDA,FDA-1995-S-0036,"Report 18 - Northfield Laboratories, Inc. - Public Disclosure Information",Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:41Z,,0,0,090000648055b0be
FDA-1995-S-0036-0090,FDA,FDA-1995-S-0036,University of Washington IDE#G980067,Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:08Z,,0,0,090000648055b0c1
FDA-1995-S-0036-0062,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:47Z,,0,0,090000648055b1b8
FDA-1995-S-0036-0069,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:52Z,,0,0,090000648055b1f1
FDA-1995-S-0036-0071,FDA,FDA-1995-S-0036,"Northfield Laboratories Inc, BB IND 10719, Poly-SFH-P Injection",Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:53Z,,0,0,090000648055b204
FDA-1995-S-0036-0073,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:55Z,,0,0,090000648055b23d
FDA-1995-S-0036-0074,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:55Z,,0,0,090000648055b296
FDA-1995-S-0036-0056,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:43Z,,0,0,090000648055b0c6
FDA-1995-S-0036-0092,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:09Z,,0,0,090000648055b0ca
FDA-1995-S-0036-0057,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:44Z,,0,0,090000648055b0cd
FDA-1995-S-0036-0058,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:44Z,,0,0,090000648055b0cf
FDA-1995-S-0036-0098,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:13Z,,0,0,090000648055b0d9
FDA-1995-S-0036-0064,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:48Z,,0,0,090000648055b1c0
FDA-1995-S-0036-0075,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:56Z,,0,0,090000648055b29a
FDA-1995-S-0036-0077,FDA,FDA-1995-S-0036,"Northfield Laboratories, Inc. (BB IND #10719) - Supplement(49)",Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:59Z,,0,0,090000648055b2c5
FDA-1995-S-0036-0101,FDA,FDA-1995-S-0036,"University of Washington - Comment re Public Disclosure Material 
IND 52,523 for Magnesium Sulfate and Diazepam Injection
After Cardiac Arrest",Other,Disclosure of Date and Information,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:05:15Z,,0,0,090000648055affb
FDA-1995-S-0036-0045,FDA,FDA-1995-S-0036,Report 6 - Baxter (INDA#6859) - Public Disclosure Information,Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:42Z,,0,0,090000648055b042
FDA-1995-S-0036-0089,FDA,FDA-1995-S-0036,"Report 18 - ""Metro Health Center"" - [Northfield Laboratories, Inc. - Public Disclosure Information]",Supporting & Related Material,RPT-Report (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:07Z,,0,0,090000648055b0bf
FDA-1995-S-0036-0081,FDA,FDA-1995-S-0036,"Report 32 - Northfield Laboratories, Inc. [BB IND 10719] - Final Public Disclosure Information",Other,RPT-Report,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:05:02Z,,0,0,09000064807b3f1a
FDA-1995-S-0036-0083,FDA,FDA-1995-S-0036,"Report 33 - Immediate Trial [Bellingham, Washington and El Paso, Texas Public Disclosure Material (IND 70,376) - Report",Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:05:03Z,,0,0,0900006480830852
FDA-1995-S-0036-0093,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:10Z,,0,0,090000648055b0d0
FDA-1995-S-0036-0096,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:12Z,,0,0,090000648055b0d4
FDA-1995-S-0036-0097,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:12Z,,0,0,090000648055b0d5
FDA-1995-S-0036-0061,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:46Z,,0,0,090000648055b139
FDA-1995-S-0036-0066,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:50Z,,0,0,090000648055b1c3
FDA-1995-S-0036-0076,FDA,FDA-1995-S-0036,Northfield Laboratories BB IND #10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:58Z,,0,0,090000648055b29f
FDA-1995-S-0036-0039,FDA,FDA-1995-S-0036,"ICOS Corporation, Community Consultation and Public Disclosure information for Waiver of Informed Consent, BB IND-7371, Public Disclosure Information, Report 3 - Report",Other,Report,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:36Z,,0,0,090000648055b012
FDA-1995-S-0036-0044,FDA,FDA-1995-S-0036,Icos Corporation BB IND-7371,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:41Z,,0,0,090000648055b02a
FDA-1995-S-0036-0046,FDA,FDA-1995-S-0036,"CPR, LLC IDE# 980125",Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:35Z,,0,0,090000648055b044
FDA-1995-S-0036-0047,FDA,FDA-1995-S-0036,"Concentric Medical, Inc.",Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:36Z,,0,0,090000648055b047
FDA-1995-S-0036-0052,FDA,FDA-1995-S-0036,Report 16 - Harborview Medical Center - Public Disclosure Information,Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:40Z,,0,0,090000648055b0b4
FDA-1995-S-0036-0054,FDA,FDA-1995-S-0036,University of Washington IDE#G980067,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:41Z,,0,0,090000648055b0c3
FDA-1995-S-0036-0034,FDA,FDA-1995-S-0036,Baxter INDA#6859,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:32Z,,0,0,090000648055aff3
FDA-1995-S-0036-0031,FDA,FDA-1995-S-0036,"Cardiologic Systems, Inc IDE G960214/S6",Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:30Z,,0,0,090000648055afed
FDA-1995-S-0036-0033,FDA,FDA-1995-S-0036,"Cardiologic Systems, Inc IDE G960214/10",Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:31Z,,0,0,090000648055aff1
FDA-1995-S-0036-0036,FDA,FDA-1995-S-0036,Baxter INDA#6859,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:34Z,,0,0,090000648055aff9
FDA-1995-S-0036-0040,FDA,FDA-1995-S-0036,"Report 4 - Cardiologic Systems, Inc IDE G960214 - Public Disclosure Information",Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:38Z,,0,0,090000648055b013
FDA-1995-S-0036-0049,FDA,FDA-1995-S-0036,"Report 12 - Northfield Laboratories, Inc. - Public Disclosure Information",Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:38Z,,0,0,090000648055b089
FDA-1995-S-0036-0051,FDA,FDA-1995-S-0036,"Report 15 - Northfield Laboratories, Inc. [BB IND # 10719] - Public Disclosure Information",Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:39Z,,0,0,090000648055b0af
FDA-1995-S-0036-0088,FDA,FDA-1995-S-0036,"Community Consultation - [Report 15 - Northfield Laboratories, Inc. [BB IND # 10719] - Public Disclosure Information]",Supporting & Related Material,RPT-Report (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:06Z,,0,0,090000648055b0b3
FDA-1995-S-0036-0091,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:08Z,,0,0,090000648055b0c8
FDA-1995-S-0036-0094,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:10Z,,0,0,090000648055b0d1
FDA-1995-S-0036-0095,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:11Z,,0,0,090000648055b0d2
FDA-1995-S-0036-0065,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:49Z,,0,0,090000648055b1c1
FDA-1995-S-0036-0072,FDA,FDA-1995-S-0036,Northfield Laboratories Inc  BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:54Z,,0,0,090000648055b232
FDA-1995-S-0036-0080,FDA,FDA-1995-S-0036,Report 20 - University of Texas Health Science Center at San Antonio,Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:05:01Z,,0,0,090000648055b2ff
FDA-1995-S-0036-0100,FDA,FDA-1995-S-0036,ROC Site and Status - [Report 23 - ROC [INDs 12505 & 12506] - Public Dislcosure Information],Supporting & Related Material,RPT-Report (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:14Z,,0,0,090000648055b44f
FDA-1995-S-0036-0055,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:42Z,,0,0,090000648055b0c5
FDA-1995-S-0036-0059,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:45Z,,0,0,090000648055b0d6
FDA-1995-S-0036-0060,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:46Z,,0,0,090000648055b0d8
FDA-1995-S-0036-0063,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:48Z,,0,0,090000648055b1b9
FDA-1995-S-0036-0067,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:50Z,,0,0,090000648055b1e7
FDA-1995-S-0036-0068,FDA,FDA-1995-S-0036,Northfield Laboratories Inc BB IND 10719,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:51Z,,0,0,090000648055b1ed
FDA-1995-S-0036-0078,FDA,FDA-1995-S-0036,"Executive Summary - [Northfield Laboratories, Inc. (BB IND #10719) - Supplement(49)]",Supporting & Related Material,SUP-Supplement (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:00Z,,0,0,090000648055b2c8
FDA-1995-S-0036-0082,FDA,FDA-1995-S-0036,"Report 2 - Cardiologic Systems, Inc. - [IDE G960214/12] - Public Disclosure Information",Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:05:03Z,,0,0,090000648055afea
FDA-1995-S-0036-0041,FDA,FDA-1995-S-0036,Baxter INDA#6859,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:39Z,,0,0,090000648055b020
FDA-1995-S-0036-0043,FDA,FDA-1995-S-0036,Icos Corporation BB IND-7371,Other,SUP-Supplement,2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:01:41Z,,0,0,090000648055b028
FDA-1995-S-0036-0086,FDA,FDA-1995-S-0036,"Listing 1 - Memphis Survey Results, October 9, 2003 - [Report 12 - Northfield Laboratories, Inc. - Public Disclosure Information] Part 1 of 2",Supporting & Related Material,RPT-Report (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:05Z,,0,0,090000648055b088
FDA-1995-S-0036-0050,FDA,FDA-1995-S-0036,"Report 14 - Northfield Laboratories, Inc. [BB IND # 10719] - Public Disclosure Information",Other,RPT-Report (outside of agency unless indicated),2009-01-29T05:00:00Z,2009,1,2009-01-29T05:00:00Z,,2021-02-05T19:04:39Z,,0,0,090000648055b0ae
FDA-1995-S-0036-0087,FDA,FDA-1995-S-0036,"Community Consultation - [Report 15 - Northfield Laboratories, Inc. [BB IND # 10719] - Public Disclosure Information]",Supporting & Related Material,RPT-Report (Supporting and Related Material),2009-01-29T05:00:00Z,2009,1,,,2021-02-05T19:05:06Z,,0,0,090000648055b0b1